NCT00436306

Brief Summary

The primary purpose of Project PROTECT was to evaluate two different intervention approaches that encourage young women to use dual methods of contraception. The individualized intervention is a computer assisted, fully-tailored, interactive intervention based on the transtheoretical model of behavior change. This intervention was compared to an enhanced standard care intervention that provided computer-based, non-tailored information and advice regarding the use of contraceptive methods. The two primary outcomes of this trial include: 1) a behavioral outcome: the reported use of dual methods of contraception; and 2) a biological outcome: an incident or recurrent STI or unintended pregnancy. The hypotheses of this trial were: 1) the individualized intervention will result in a greater increase in dual contraceptive use than the standard care approach; and 2) the individualized intervention would result in greater protection against incident or recurrent cases of sexually transmitted infections and unplanned pregnancies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Oct 1999

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 1999

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2005

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 15, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 19, 2007

Completed
Last Updated

October 8, 2015

Status Verified

October 1, 2015

Enrollment Period

6.2 years

First QC Date

February 15, 2007

Last Update Submit

October 6, 2015

Conditions

Keywords

preventionbehaviorrisk reduction behavior

Outcome Measures

Primary Outcomes (2)

  • Behavioral: reported use of dual methods of contraception

    Outcome: ANY use of dual methods of contraception. Also evaluated consistent condom use.

    24 months

  • Biological: incident sexually transmitted infection or unintended pregnancy

    ANY sexually transmitted infection OR unintended pregnancy.

    24 months

Secondary Outcomes (2)

  • Secondary outcomes will include intermediate outcomes variables such as

    24 months

  • changes in stage of change, processes of change, decisional balance, and self-efficacy.

    24 months

Study Arms (2)

Individualized Intervention: stage-matched/tailored counseling

EXPERIMENTAL

Individualized Intervention is a computer-based, stage-matched, tailored intervention to promote the use of dual methods of contraception for STD and unplanned pregnancy prevention.

Behavioral: Individualized InterventionBehavioral: Computer-based contraceptive information

Control: Enhanced usual care counseling

PLACEBO COMPARATOR

The Enhanced Usual Care arm was the control group. It provided computer-based information regarding contraceptive methods, but was not individualized or tailored to the participant stage of change.

Behavioral: Computer-based contraceptive information

Interventions

Individualized Intervention is a computer-based, stage-matched, tailored intervention to promote the use of dual methods of contraception for STD and unplanned pregnancy prevention.

Individualized Intervention: stage-matched/tailored counseling

Contraceptive method information is provided on a computer.

Control: Enhanced usual care counselingIndividualized Intervention: stage-matched/tailored counseling

Eligibility Criteria

Age13 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • English-speaking
  • Sexually active with a male partner in the past 6 months
  • Desire to avoid conception for 24 months or more
  • High risk for unintended pregnancy or STI:
  • Age less than 25
  • Age 25 and older with:
  • History of unplanned pregnancy
  • History of a sexually transmitted infection
  • Inconsistent use of contraception
  • Other factors felt to place a patient at above average risk for unplanned pregnancy or STI

You may not qualify if:

  • currently using dual methods of contraception consistently and correctly.
  • incompetent or unable to give consent;
  • currently pregnant or desires pregnancy in the next 24 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women & Infants Hospital

Providence, Rhode Island, 02905, United States

Location

Related Publications (10)

  • Peipert J, Redding CA, Blume J, Allsworth JE, Iannuccillo K, Lozowski F, Mayer K, Morokoff PJ, Rossi JS. Design of a stage-matched intervention trial to increase dual method contraceptive use (Project PROTECT). Contemp Clin Trials. 2007 Sep;28(5):626-37. doi: 10.1016/j.cct.2007.01.012. Epub 2007 Feb 7.

    PMID: 17374567BACKGROUND
  • Matteson KA, Peipert JF, Allsworth J, Phipps MG, Redding CA. Unplanned pregnancy: does past experience influence the use of a contraceptive method? Obstet Gynecol. 2006 Jan;107(1):121-7. doi: 10.1097/01.AOG.0000192170.16746.ea.

  • Peipert JF, Lapane KL, Allsworth JE, Redding CA, Blume JL, Lozowski F, Stein MD. Women at risk for sexually transmitted diseases: correlates of intercourse without barrier contraception. Am J Obstet Gynecol. 2007 Nov;197(5):474.e1-8. doi: 10.1016/j.ajog.2007.03.032. Epub 2007 Aug 21.

  • Peipert JF, Lapane KL, Allsworth JE, Redding CA, Blume JD, Stein MD. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? Sex Transm Dis. 2008 Apr;35(4):363-7. doi: 10.1097/OLQ.0b013e31815e4179.

  • Krings KM, Matteson KA, Allsworth JE, Mathias E, Peipert JF. Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception? Am J Obstet Gynecol. 2008 May;198(5):e46-7. doi: 10.1016/j.ajog.2007.12.025. Epub 2008 Mar 7.

  • Peipert JF, Redding CA, Blume JD, Allsworth JE, Matteson KA, Lozowski F, Mayer KH, Morokoff PJ, Rossi JS. Tailored intervention to increase dual-contraceptive method use: a randomized trial to reduce unintended pregnancies and sexually transmitted infections. Am J Obstet Gynecol. 2008 Jun;198(6):630.e1-8. doi: 10.1016/j.ajog.2008.01.038. Epub 2008 Apr 8.

  • Kuroki LM, Allsworth JE, Redding CA, Blume JD, Peipert JF. Is a previous unplanned pregnancy a risk factor for a subsequent unplanned pregnancy? Am J Obstet Gynecol. 2008 Nov;199(5):517.e1-7. doi: 10.1016/j.ajog.2008.03.049. Epub 2008 May 12.

  • Allsworth JE, Anand M, Redding CA, Peipert JF. Physical and sexual violence and incident sexually transmitted infections. J Womens Health (Larchmt). 2009 Apr;18(4):529-34. doi: 10.1089/jwh.2007.0757.

  • Allsworth JE, Peipert JF. Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol. 2011 Aug;205(2):113.e1-6. doi: 10.1016/j.ajog.2011.02.060. Epub 2011 Feb 27.

  • Peipert JF, Zhao Q, Meints L, Peipert BJ, Redding CA, Allsworth JE. Adherence to dual-method contraceptive use. Contraception. 2011 Sep;84(3):252-8. doi: 10.1016/j.contraception.2011.01.023. Epub 2011 Apr 16.

MeSH Terms

Conditions

Sexually Transmitted DiseasesBehaviorRisk Reduction Behavior

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jeffrey F Peipert, MD, MPH

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Robert J. Terry Professor

Study Record Dates

First Submitted

February 15, 2007

First Posted

February 19, 2007

Study Start

October 1, 1999

Primary Completion

December 1, 2005

Study Completion

December 1, 2005

Last Updated

October 8, 2015

Record last verified: 2015-10

Locations